Skip to main content
. 2022 Jan 21;17(1):e0262074. doi: 10.1371/journal.pone.0262074

Table 1. Comparison of the general clinical parameters for the patients.

GU patients Chronic OA patients p
VAS score 0–1 (control) VAS score 0–2 (very mild pain) VAS score ≥ 3 (pain)
N 14 8 21
Age (years, mean ± SD) 57.3 ± 8.7 59.9 ± 6.6 62.2 ± 7.6 F = 1.661a 0.203
Female sex, n (%) 6 (42.9) 7 (87.5) 15 (71.4) χ2 = 5.187b 0.075
Body weight (kg, mean ± SD) 66.5 ± 6.9 73.1 ± 15.9 69.9 ± 13.1 F = 0.793a 0.459
BMI (kg/m2, mean ± SD) 25.5 ± 2.8 28.6 ± 4.8 28.6 ± 4.6 F = 2.737a 0.077
Hypertension, n (%) 3 (21.4) 2 (25.0) 12 (57.1) χ2 = 5.351b 0.069
DM, n (%) 1 (7.1) 1 (12.5) 6 (28.6) χ2 = 2.789b 0.248
Mean VAS pain score (mean ± SD) 0.3 ± 0.6 1.5 ± 0.8** 3.4 ± 0.7***### F = 85.907a < 0.0001
Duration of pain (day, mean ± SD) 75.1 ± 186.6 1665.0 ± 1200.0*** 1060.0 ± 921.9** F = 10.635a < 0.0001
Pain-relieving drugs used, n (%) 5 (35.7) 1 (12.5) 7 (31.8) χ2 = 1.488b 0.475
    Opioid, n 0 0 0
    NSAID, n 2 1 6
    Acetaminophen, n 3 0 1
Operation (n) Hernia (2) OA hip replacement (2) OA hip replacement (3)
Hydrocele (1) OA knee replacement (6) OA knee replacement (17)
Ureterscope (11) Knee arthroscopy (1)

GU, genitourinary examination or operation. OA, osteoarthritis. VAS, Visual Analogue Scale. BMI, body mass index. DM, diabetes mellitus. NSAIDS, nonsteroidal anti-inflammatory drugs (etoricoxib, naproxen). Patients with GU diseases without obvious pain (VAS score 0–1 at rest) were included as a comparison (control) group. Patients with OA were divided into very mild pain (VAS score 0–2) and pain (VAS score ≥ 3) groups according to their level of pain. Data were presented as means ± standard deviation (SD), n, or n (%).

aOne-way ANOVA with a Bonferroni post-hoc multiple comparison

**p < 0.001

***p < 0.0001 vs. GU control patients

###p < 0.0001 vs. OA patients with very mild pain.

bAnalysis of χ2 test.